Redcare Pharmacy beats Q3 core earnings view on higher sales
31/10/2023 06:18
Oct 31 (Reuters) - Netherlands-based Redcare Pharmacy
RDC.DE on Tuesday beat third-quarter adjusted core earnings
expectations, supported by a 67% growth in sales.
The group achieved adjusted earnings before interests,
taxes, depreciation and amortization (EBITDA) including
MediService AG of 15.2 million euros ($16.1 million), nearly
double the company-compiled consensus of 7.9 million euros.
The online pharmacy operator recorded a 49% sales growth in
its core DACH market, which comprises Austria, Germany, and
Switzerland, in the first nine months of the year.
Furthermore, it affirmed its outlook for 2023, which it had
raised during the release of its second-quarter results in
August.
Swiss peer DocMorris DOCM.S trimmed its full-year outlook
as it released its third-quarter results, following a decline in
paper prescriptions.
($1 = 0.9438 euros)
(Reporting by Tristan Veyet and Paolo Laudani; Editing by Varun
H K)
((Tristan.Chabba@thomsonreuters.com;
Paolo.laudani@thomsonreuters.com))